GlassScriptPhysician profile
Paul Ghattas
NPI 1962857599
$5,597.67
in general payments reported to CMS, 2019-2025
11 companies · $3,575 in 2025
The $3,575 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2023: $1,279 · 2024: $537 · 2025: $3,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,733 · Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,733.38 |
| Food and Beverage | $1,158.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,457.17 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,075.35 | 2023 | Advantagerib |
| Smith+Nephew, INC. | $382.17 | 2023-2025 | Oasis, Stravix, Stravix Pl |
| Boston Scientific Corporation | $290.54 | 2023-2024 | Axios, Spyglass Discover |
| Kci USA, INC. | $205.96 | 2019 | |
| Ethicon US, LLC | $59.11 | 2023-2024 | Harmonic, Stratafix, Surgicel Nu-Knit |
| Davol INC. | $55.21 | 2025 | Phasix Mesh |
| Baxter Healthcare | $22.50 | 2024 | Perclot, Seprafilm, Floseal |
| Pacira Pharmaceuticals Incorporated | $22.38 | 2024 | Exparel |
| Becton, Dickinson and Company | $13.88 | 2025 | Arista |
| Tela Bio, INC. | $13.40 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ghattas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.